PROVIDENCE-1: Study of Rifalazil in Chlamydia Pneumoniae Seropositive Patients

PHASE3UnknownINTERVENTIONAL
Enrollment

274

Participants

Timeline

Start Date

November 30, 2005

Study Completion Date

December 31, 2007

Conditions
Peripheral Vascular DiseasesIntermittent Claudication
Interventions
DRUG

Rifalazil

Trial Locations (48)

19115

Radiant Research, Philadelphia

23294

National Clinical Research, Richmond

23502

Hampton Roads Center for Clinical Research, Norfolk

27705

Durham VA Medical Center, Durham

30094

Rockdale Medical Research Associates, Conyers

32216

Jacksonville Center for Clinical Research, Jacksonville

33024

University Clinical Research, Pembrook Pines

33761

Tampa Bay Medical Research, Inc., Clearwater

34239

Cardiovascular Center of Sarasota, Sarasota

46290

The Care Group, Indianapolis

54401

Care Foundation, Wausau

57701

Black Hills Clinical Research Center, Rapid City

63104

St. Louis University, St Louis

80218

Aurora Denver Cardiology Associates, Denver

85251

Scottsdale Cardiovascular Research Institute, Scottsdale

92103

Siddeg, Inc., San Diego

92705

Apex Research Institute, Santa Ana

94304

VA Palo Alto Health Care System, Palo Alto

95405

Radiant Research, Santa Rosa

97219

New Hope Research of Oregon, Inc., Portland

113093

Vishnevsky Institute of Surgery, Moscow

115516

Russian State Medical University, Moscow

117049

Russian State Medical University, Moscow

125367

Central Clinical Hospital #1, Moscow

192242

Dzhanelidze Emergency Medicine Research Institutes, Saint Petersburg

Saint Petersburg Djanelidze Research Institute of First Aid, Saint Petersburg

194100

Saint Petersburg State Medical Pediatric Academy, Saint Petersburg

194156

Research Institute of Cardiology n.a. Almazov, Saint Petersburg

194354

City Hospital #2, Saint Petersburg

196247

City Hospital #26, Saint Petersburg

197022

Saint Petersburg Pavlov Medical University, Saint Petersburg

199106

Pokrovskaya Hospital, Saint Petersburg

214000

Clinical Hospital #1, Smolensk

400138

Clinical City Hospital # 25, Volgograd

410017

City Clinical Hospital # 1, Saratov

600023

Regional Clinical Hospital, Vladimir

603018

City Hospital # 13, Nizhny Novgorod

630055

Meshalkin Research Institute of Blood Circulation Pathology, Novosibirsk

643012

Tomsk Research Center, Tomsk

04210

Androscoggin Cardiology Associates, Auburn

01655

University of Massachusetts Medical Center, Worcester

02886

Omega Medical Research, Warwick

09030-010

Hospital e Maternidade Dr. Christovao da Gama, Santo André

18031-000

Centro de Ciencias Medicas e Biologicas da Pontificia Universidade, Sorocaba

18618-970

Depto de Cirurgia e ortopedia, Botucatu

70330-150

SMHS - Area Especial, Brasília

Unknown

Hospital Pedro Ernesto, Rio de Janeiro

15015-210

Instituto de molestias cardiovasculares, São José do Rio Preto

Sponsors

Lead Sponsor

All Listed Sponsors
lead

ActivBiotics

INDUSTRY

NCT00251849 - PROVIDENCE-1: Study of Rifalazil in Chlamydia Pneumoniae Seropositive Patients | Biotech Hunter | Biotech Hunter